Search - Université de Rennes Access content directly

Filter your results

11 Results
authFullName_s : Pauline Brice

Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

Loic Ysebaert , Roch Houot , Ibrahim Yakoub-Agha , Franck Morschhauser , Charles Herbaux et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles hal-01290424v1

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program

Roch Houot , Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean Marc Schiano de Collela et al.
Blood, 2018, 132 (1), pp.1638. ⟨10.1182/blood-2018-99-110960⟩
Journal articles hal-02076926v1
Image document

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)

Guillaume Manson , Charles Herbaux , Jean Marc Schiano de Colella , René-Olivier Casasnovas , Aspasia Stamatoullas et al.
British Journal of Haematology, 2022, 198 (1), pp.203-206. ⟨10.1111/bjh.18198⟩
Journal articles hal-03665134v1

Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS).

Franck Morschhauser , Nicolas Mounier , Catherine Sebban , Pauline Brice , Phillippe Solal-Celigny et al.
Cancer, 2010, 116 (18), pp.4299-308. ⟨10.1002/cncr.25280⟩
Journal articles hal-00744246v1
Image document

Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation

Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean-Marc Schiano , Olivier Casasnovas et al.
European Journal of Cancer, 2019, 115, pp.47-56. ⟨10.1016/j.ejca.2019.04.006⟩
Journal articles hal-02134578v1

Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program

Aurore Perrot , Hélène Monjanel , Reda Bouabdallah , Philippe Quittet , Clémentine Sarkozy et al.
Journal articles hal-01259439v1
Image document

Prolonged remissions after anti-PD1 discontinuation in patients with Hodgkin lymphoma

Guillaume Manson , Charles Herbaux , Pauline Brice , Krimo Bouabdallah , Aspasia Stamatoullas et al.
Blood, 2018, 131 (25), pp.2856-2859. ⟨10.1182/blood-2018-03-841262⟩
Journal articles hal-01812478v1
Image document

Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies

Laurent Dercle , Fatima-Zohra Mokrane , Jean Marc Schiano de Colella , Apasia Stamatoullas , Franck Morschhauser et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 (6), pp.1391-1392. ⟨10.1007/s00259-019-04310-x⟩
Journal articles hal-02119287v1
Image document

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

Emmanuel Bachy , Roch Houot , Franck Morschhauser , Anne Sonet , Pauline Brice et al.
Haematologica, 2013, 98 (7), pp.1107-14. ⟨10.3324/haematol.2012.082412⟩
Journal articles hal-00933219v1
Image document

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Sarah Huet , Bruno Tesson , Jean-Philippe Jais , Andrew Feldman , Laura Magnano et al.
Lancet Oncology, 2018, 19 (4), pp.549 - 561. ⟨10.1016/S1470-2045(18)30102-5⟩
Journal articles hal-01788996v1
Image document

Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation

Guillaume Manson , Pauline Brice , Charles Herbaux , Kamal Bouabdallah , Chloé Antier et al.
Haematologica, 2020, 105 (11), pp.2664-2666. ⟨10.3324/haematol.2019.242529⟩
Journal articles hal-02485796v1